Fenton Mary Kay has been a registered insider since 2003.
As Chief Financial Officer at Achillion Pharmaceuticals, Inc., Fenton Mary Kay last made a transaction on 12/5/2016.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 3 |
0% |
-46% |
-33% |
46 |
1 Year |
3 |
0% |
-- |
-- |
-- |
| 3 |
33% |
-29% |
-36% |
89 |
9 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
33% |
-28% |
-33% |
79 |
6 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
0% |
-41% |
-55% |
59 |
3 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
33% |
-22% |
-22% |
50 |
1 Month |
3 |
0% |
-- |
-- |
-- |
| 3 |
0% |
-4% |
-6% |
9 |
1 Week |
3 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 6 |
50% |
13% |
7% |
191 |
1 Year |
6 |
0% |
-- |
-- |
-- |
| 6 |
50% |
-7% |
-3% |
76 |
9 Month |
6 |
0% |
-- |
-- |
-- |
| 6 |
83% |
-23% |
-39% |
106 |
6 Month |
6 |
0% |
-- |
-- |
-- |
| 6 |
67% |
-7% |
-7% |
74 |
3 Month |
6 |
0% |
-- |
-- |
-- |
| 6 |
83% |
-19% |
-22% |
41 |
1 Month |
6 |
0% |
-- |
-- |
-- |
| 6 |
100% |
-6% |
-7% |
6 |
1 Week |
6 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/13/2023 11:10 PM EST |
Latest Transaction Date: |
12/5/2016 |
| Average days between Transaction and Entered Dates: |
5 |
